alexa
 
Home News Glenmark Pharmaceuticals receives tentative ANDA approval

Read more interesting news from around the globe with Wealth Doctor App

Google Play
 
Glenmark Pharmaceuticals receives tentative ANDA approval

Glenmark Pharmaceuticals receives tentative ANDA approval

Friday, March 31, 2017, 10:16 AM

Glenmark Pharmaceuticals Inc., USA (Glenmark), has been granted tentative approval by the United States Food & Drug Administration for Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg, the generic version of Savella Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg of Allergan Sales, LLC. Glenmark Pharma's stock is trading higher by 0.4% on BSE at Rs 867.4/share.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!